Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Community Projects (beta) QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor
go back to main search page
Accession:CHEBI:76808 term browser browse the term
Definition:An EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor that interferes with the action of any non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*).
Synonyms:related_synonym: EC 3.5.2.* inhibitor;   EC 3.5.2.* inhibitors;   non-peptide cyclic amide C-N hydrolase (EC 3.5.2.*) inhibitors;   non-peptide cyclic amide C-N hydrolase inhibitor;   non-peptide cyclic amide C-N hydrolase inhibitors


show annotations for term's descendants           Sort by:
Augmentin term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of ABCB11 mRNA CTD PMID:34767876 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324 		JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412 		JBrowse link
G CASP3 caspase 3 increases activity ISO Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP3 protein CTD PMID:30273099 NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062 		JBrowse link
G CASP9 caspase 9 increases activity ISO Amoxicillin-Potassium Clavulanate Combination results in increased activity of CASP9 protein CTD PMID:30273099 NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of CXCL8 protein CTD PMID:11390425 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CYCS cytochrome c, somatic increases secretion ISO Amoxicillin-Potassium Clavulanate Combination results in increased secretion of CYCS protein CTD PMID:30273099 NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260 		JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293 		JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163 		JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898 		JBrowse link
G FGF19 fibroblast growth factor 19 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022 		JBrowse link
G G6PD glucose-6-phosphate dehydrogenase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456 		JBrowse link
G GGT1 gamma-glutamyltransferase 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GGT1 protein CTD PMID:34767876 NCBI chr22:24,583,750...24,628,996
Ensembl chr22:24,594,811...24,629,005 		JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 increases activity ISO Amoxicillin-Potassium Clavulanate Combination results in increased activity of GOT1 protein CTD PMID:30273099 NCBI chr10:99,396,870...99,430,624
Ensembl chr10:99,396,870...99,430,624 		JBrowse link
G GPT glutamic--pyruvic transaminase increases activity ISO Amoxicillin-Potassium Clavulanate Combination results in increased activity of GPT protein CTD PMID:30273099 NCBI chr 8:144,503,068...144,507,172
Ensembl chr 8:144,502,973...144,507,174 		JBrowse link
G GPX2 glutathione peroxidase 2 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746 		JBrowse link
G GSR glutathione-disulfide reductase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846 		JBrowse link
G ME1 malic enzyme 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975 		JBrowse link
G SLC10A1 solute carrier family 10 member 1 decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241 		JBrowse link
G SLC51A solute carrier family 51 member A decreases expression EXP Amoxicillin-Potassium Clavulanate Combination results in decreased expression of SLC51A mRNA CTD PMID:34767876 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of SLC7A11 mRNA CTD PMID:34767876 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G TKT transketolase increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052 		JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP Amoxicillin-Potassium Clavulanate Combination results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
ceftriaxone term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE2 angiotensin converting enzyme 2 decreases expression ISO Ceftriaxone results in decreased expression of ACE2 mRNA CTD PMID:29745864 NCBI chr  X:15,518,197...15,607,211
Ensembl chr  X:15,494,566...15,607,236 		JBrowse link
G ACTB actin beta increases expression ISO Ceftriaxone results in increased expression of ACTB mRNA CTD PMID:29745864 NCBI chr 7:5,527,148...5,530,601
Ensembl chr 7:5,526,409...5,563,902 		JBrowse link
G BACE1 beta-secretase 1 decreases expression ISO Ceftriaxone results in decreased expression of BACE1 mRNA CTD PMID:29745864 NCBI chr11:117,285,698...117,316,256
Ensembl chr11:117,285,232...117,316,259 		JBrowse link
G CAT catalase decreases expression
multiple interactions		 ISO Ceftriaxone results in decreased expression of CAT protein
Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased activity of CAT protein]]		 CTD PMID:19442074 PMID:25053526 NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060 		JBrowse link
G DHFR dihydrofolate reductase decreases activity EXP Ceftriaxone results in decreased activity of DHFR protein CTD PMID:25418905 NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983 		JBrowse link
G ECE1 endothelin converting enzyme 1 increases expression ISO Ceftriaxone results in increased expression of ECE1 mRNA CTD PMID:29745864 NCBI chr 1:21,217,250...21,345,504
Ensembl chr 1:21,217,247...21,345,572 		JBrowse link
G EPO erythropoietin increases expression ISO Ceftriaxone results in increased expression of EPO mRNA CTD PMID:29745864 NCBI chr 7:100,720,468...100,723,700
Ensembl chr 7:100,720,468...100,723,700 		JBrowse link
G IDE insulin degrading enzyme increases expression ISO Ceftriaxone results in increased expression of IDE mRNA CTD PMID:29745864 NCBI chr10:92,451,684...92,574,093
Ensembl chr10:92,451,684...92,574,096 		JBrowse link
G IL1B interleukin 1 beta multiple interactions ISO Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of IL1B protein]] CTD PMID:25053526 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G MME membrane metalloendopeptidase increases expression ISO Ceftriaxone results in increased expression of MME mRNA CTD PMID:29745864 NCBI chr 3:155,024,202...155,183,729
Ensembl chr 3:155,024,124...155,183,704 		JBrowse link
G SLC1A2 solute carrier family 1 member 2 multiple interactions
increases expression		 ISO Ceftriaxone inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC1A2 protein]; Ceftriaxone inhibits the reaction [JZL195 results in decreased expression of and affects the folding of SLC1A2 protein]; Ceftriaxone promotes the reaction [Kainic Acid results in increased expression of SLC1A2 protein]
Ceftriaxone results in increased expression of SLC1A2 protein		 CTD PMID:19625514 PMID:19717140 PMID:28257918 PMID:29045497 PMID:29432698 NCBI chr11:35,251,205...35,420,507
Ensembl chr11:35,251,205...35,420,063 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 multiple interactions ISO Ceftriaxone inhibits the reaction [Cocaine results in decreased expression of SLC7A11 protein] CTD PMID:19717140 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]; ropinirole promotes the reaction [Ceftriaxone inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in increased expression of TNF protein]] CTD PMID:25053526 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
clavulanic acid term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB11 ATP binding cassette subfamily B member 11 decreases expression
multiple interactions		 EXP Clavulanic Acid results in decreased expression of ABCB11 mRNA
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCB11 mRNA]		 CTD PMID:34767876 NCBI chr 2:168,915,390...169,031,324
Ensembl chr 2:168,915,498...169,031,324 		JBrowse link
G ABCB4 ATP binding cassette subfamily B member 4 decreases expression EXP Clavulanic Acid results in decreased expression of ABCB4 mRNA CTD PMID:34767876 NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435 		JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 increases expression EXP Clavulanic Acid results in increased expression of ABCC2 mRNA CTD PMID:34767876 NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594 		JBrowse link
G ABCG5 ATP binding cassette subfamily G member 5 multiple interactions
decreases expression		 EXP Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ABCG5 mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ABCG5 mRNA] CTD PMID:34767876 NCBI chr 2:43,806,211...43,839,231
Ensembl chr 2:43,812,472...43,838,865 		JBrowse link
G ADH1A alcohol dehydrogenase 1A (class I), alpha polypeptide multiple interactions
decreases expression		 EXP Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of ADH1A mRNA]; GW 4064 inhibits the reaction [Clavulanic Acid results in decreased expression of ADH1A mRNA] CTD PMID:34767876 NCBI chr 4:99,276,369...99,290,985
Ensembl chr 4:99,276,369...99,291,003 		JBrowse link
G AKR1B10 aldo-keto reductase family 1 member B10 increases expression EXP Clavulanic Acid results in increased expression of AKR1B10 mRNA CTD PMID:34767876 NCBI chr 7:134,527,567...134,541,412
Ensembl chr 7:134,527,567...134,541,412 		JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 decreases expression
increases expression		 EXP Clavulanic Acid results in decreased expression of CXCL8 mRNA
Clavulanic Acid results in increased expression of CXCL8 mRNA		 CTD PMID:32816093 NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716 		JBrowse link
G CYP27A1 cytochrome P450 family 27 subfamily A member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP27A1 mRNA CTD PMID:34767876 NCBI chr 2:218,782,147...218,815,293
Ensembl chr 2:218,781,749...218,815,293 		JBrowse link
G CYP7A1 cytochrome P450 family 7 subfamily A member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP7A1 mRNA CTD PMID:34767876 NCBI chr 8:58,490,178...58,500,163
Ensembl chr 8:58,490,178...58,500,163 		JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 decreases expression EXP Clavulanic Acid results in decreased expression of CYP8B1 mRNA CTD PMID:34767876 NCBI chr 3:42,872,192...42,875,879
Ensembl chr 3:42,856,005...42,875,898 		JBrowse link
G EREG epiregulin decreases expression
increases expression		 EXP Clavulanic Acid results in decreased expression of EREG mRNA
Clavulanic Acid results in increased expression of EREG mRNA		 CTD PMID:32816093 NCBI chr 4:74,365,145...74,388,749
Ensembl chr 4:74,365,145...74,388,749 		JBrowse link
G FGF19 fibroblast growth factor 19 increases expression EXP Clavulanic Acid results in increased expression of FGF19 mRNA CTD PMID:34767876 NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022 		JBrowse link
G G6PD glucose-6-phosphate dehydrogenase increases expression EXP Clavulanic Acid results in increased expression of G6PD mRNA CTD PMID:34767876 NCBI chr  X:154,531,390...154,547,569
Ensembl chr  X:154,517,825...154,547,572 		JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit increases expression EXP Clavulanic Acid results in increased expression of GCLC mRNA CTD PMID:34767876 NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970 		JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit increases expression EXP Clavulanic Acid results in increased expression of GCLM mRNA CTD PMID:34767876 NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456 		JBrowse link
G GPX2 glutathione peroxidase 2 increases expression EXP Clavulanic Acid results in increased expression of GPX2 mRNA CTD PMID:34767876 NCBI chr14:64,939,158...64,942,745
Ensembl chr14:64,939,152...64,942,746 		JBrowse link
G GSR glutathione-disulfide reductase increases expression EXP Clavulanic Acid results in increased expression of GSR mRNA CTD PMID:34767876 NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846 		JBrowse link
G IL1A interleukin 1 alpha increases expression EXP Clavulanic Acid results in increased expression of IL1A mRNA CTD PMID:32816093 NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493 		JBrowse link
G IL1B interleukin 1 beta increases expression EXP Clavulanic Acid results in increased expression of IL1B mRNA CTD PMID:32816093 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G IL24 interleukin 24 increases expression
decreases expression		 EXP Clavulanic Acid results in increased expression of IL24 mRNA
Clavulanic Acid results in decreased expression of IL24 mRNA		 CTD PMID:32816093 NCBI chr 1:206,897,443...206,904,139
Ensembl chr 1:206,897,443...206,904,139 		JBrowse link
G LSS lanosterol synthase decreases expression EXP Clavulanic Acid results in decreased expression of LSS mRNA CTD PMID:34767876 NCBI chr21:46,188,446...46,228,774
Ensembl chr21:46,188,141...46,228,824 		JBrowse link
G ME1 malic enzyme 1 increases expression EXP Clavulanic Acid results in increased expression of ME1 mRNA CTD PMID:34767876 NCBI chr 6:83,210,402...83,431,051
Ensembl chr 6:83,210,402...83,431,051 		JBrowse link
G MET MET proto-oncogene, receptor tyrosine kinase increases expression EXP Clavulanic Acid results in increased expression of MET mRNA CTD PMID:32816093 NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377 		JBrowse link
G MVK mevalonate kinase decreases expression EXP Clavulanic Acid results in decreased expression of MVK mRNA CTD PMID:34767876 NCBI chr12:109,573,272...109,598,125
Ensembl chr12:109,573,255...109,598,125 		JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 increases expression EXP Clavulanic Acid results in increased expression of NR0B2 mRNA CTD PMID:34767876 NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975 		JBrowse link
G SCD stearoyl-CoA desaturase decreases expression EXP Clavulanic Acid results in decreased expression of SCD mRNA CTD PMID:34767876 NCBI chr10:100,347,233...100,364,826
Ensembl chr10:100,347,233...100,364,826 		JBrowse link
G SLC10A1 solute carrier family 10 member 1 decreases expression EXP Clavulanic Acid results in decreased expression of SLC10A1 mRNA CTD PMID:34767876 NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241 		JBrowse link
G SLC51A solute carrier family 51 member A decreases expression
multiple interactions		 EXP Clavulanic Acid results in decreased expression of SLC51A mRNA
Clavulanic Acid inhibits the reaction [GW 4064 results in increased expression of SLC51A mRNA]		 CTD PMID:34767876 NCBI chr 3:196,216,534...196,233,427
Ensembl chr 3:196,211,487...196,243,178 		JBrowse link
G SLC7A11 solute carrier family 7 member 11 increases expression
decreases expression		 EXP Clavulanic Acid results in increased expression of SLC7A11 mRNA
Clavulanic Acid results in decreased expression of SLC7A11 mRNA		 CTD PMID:32816093 PMID:34767876 NCBI chr 4:138,164,097...138,312,671
Ensembl chr 4:138,164,097...138,242,349 		JBrowse link
G SLPI secretory leukocyte peptidase inhibitor increases expression EXP Clavulanic Acid results in increased expression of SLPI mRNA CTD PMID:32816093 NCBI chr20:45,252,239...45,254,564
Ensembl chr20:45,252,239...45,254,564 		JBrowse link
G SREBF1 sterol regulatory element binding transcription factor 1 decreases expression EXP Clavulanic Acid results in decreased expression of SREBF1 mRNA CTD PMID:34767876 NCBI chr17:17,811,334...17,836,986
Ensembl chr17:17,810,399...17,837,002 		JBrowse link
G TKT transketolase increases expression EXP Clavulanic Acid results in increased expression of TKT mRNA CTD PMID:34767876 NCBI chr 3:53,224,712...53,256,022
Ensembl chr 3:53,224,712...53,256,052 		JBrowse link
G TNFAIP6 TNF alpha induced protein 6 increases expression EXP Clavulanic Acid results in increased expression of TNFAIP6 mRNA CTD PMID:32816093 NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046 		JBrowse link
G TXNRD1 thioredoxin reductase 1 increases expression EXP Clavulanic Acid results in increased expression of TXNRD1 mRNA CTD PMID:34767876 NCBI chr12:104,215,779...104,350,307
Ensembl chr12:104,215,779...104,350,307 		JBrowse link
salsalate term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL6 interleukin 6 affects expression ISO salicylsalicylic acid affects the expression of IL6 protein CTD PMID:20876710 NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002 		JBrowse link
G NOS3 nitric oxide synthase 3 multiple interactions ISO salicylsalicylic acid affects the expression of and affects the phosphorylation of NOS3 protein CTD PMID:20876710 NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588 		JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit affects expression ISO salicylsalicylic acid affects the expression of RELA protein CTD PMID:20876710 NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090 		JBrowse link
G SOD2 superoxide dismutase 2 affects expression ISO salicylsalicylic acid affects the expression of SOD2 protein CTD PMID:20876710 NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 		JBrowse link
G VEGFA vascular endothelial growth factor A affects expression ISO salicylsalicylic acid affects the expression of VEGFA protein CTD PMID:20876710 NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487 		JBrowse link
tazobactam term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G IL1B interleukin 1 beta multiple interactions ISO Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of IL1B mRNA] CTD PMID:16369182 NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816 		JBrowse link
G TNF tumor necrosis factor multiple interactions ISO Ozone promotes the reaction [[tazobactam co-treated with Piperacillin] results in increased expression of TNF mRNA] CTD PMID:16369182 NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 25983
    role 25896
      biological role 25875
        biochemical role 25108
          enzyme inhibitor 22235
            EC 3.* (hydrolase) inhibitor 21516
              EC 3.5.* (hydrolases acting on non-peptide C-N bonds) inhibitor 21077
                EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor 56
                  EC 3.5.2.6 (beta-lactamase) inhibitor + 56
paths to the root